Berman Capital Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$8K Buy
143
+48
+51% +$2.64K ﹤0.01% 1263
2021
Q2
$4K Buy
95
+70
+280% +$3.36K ﹤0.01% 1415
2021
Q1
$1K Buy
25
+17
+213% +$714 ﹤0.01% 1678
2020
Q4
$0 Hold
8
﹤0.01% 1784
2020
Q3
$0 Sell
8
-55
-87% -$2.04K ﹤0.01% 1730
2020
Q2
$2K Buy
63
+55
+688% +$2.2K ﹤0.01% 1305
2020
Q1
$0 Hold
8
﹤0.01% 1617
2019
Q4
$0 Hold
8
﹤0.01% 1523
2019
Q3
$0 Hold
8
﹤0.01% 1544
2019
Q2
$0 Hold
8
﹤0.01% 1552
2019
Q1
$0 Hold
8
﹤0.01% 1444
2018
Q4
$0 Buy
+8
New +$292 ﹤0.01% 1226

Other funds holding PBH

Berman Capital Advisors's PBH Position: Q3 2021 in Review

Berman Capital Advisors increased its Prestige Consumer Healthcare (PBH) stake by 51% in Q3 2021, buying an estimated $2.64K and bringing the position to 143 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Berman Capital Advisors first reported a position in PBH in Q4 2018 and has held it in 12 quarters since. 248 funds tracked by Wall St. Rank hold PBH as of Q3 2021.

  • Berman Capital Advisors held 143 shares of Prestige Consumer Healthcare worth $8K as of Q3 2021.
  • Berman Capital Advisors bought 48 Prestige Consumer Healthcare shares in Q3 2021, an estimated $2.64K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1263 holding.
  • Berman Capital Advisors first reported a position in Prestige Consumer Healthcare in Q4 2018 and has held it in 12 quarters since.
  • 248 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.